VIVE OTC
Viveve Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$13M
+15.5% ▲
Capital Expenditures
$456K
+41.6% ▲
5Y CAGR: +12.2%
Free Cash Flow
-$13M
+16.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$13M
+286.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$37M | -$50M | -$43M | -$22M | -$22M |
| Depreciation & Amort. | $449K | $786K | $1M | $1M | $1M |
| Stock-Based Comp. | $2M | $3M | $2M | $3M | $4M |
| Change in Working Capital | -$1M | $398K | -$2M | -$497K | $4M |
| Other Non-Cash Items | $1M | $2M | $9M | $918K | $862K |
| Operating Cash Flow | -$35M | -$43M | -$31M | -$15M | -$13M |
| — Investing Activities — | |||||
| Capital Expenditures | -$905K | -$2M | -$1M | -$781K | -$456K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$2M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3M | -$2M | -$1M | -$781K | -$456K |
| — Financing Activities — | |||||
| Net Debt Issuance | $19M | $0 | $0 | $1M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$378K | $0 | $0 |
| Other Financing | $127K | $233K | $212K | $8M | $147K |
| Financing Cash Flow | $51M | $54M | $16M | $9M | $26M |
| Net Change in Cash | $13M | $9M | -$16M | -$7M | $13M |
| Cash End of Period | $21M | $30M | $13M | $7M | $19M |
| Free Cash Flow | -$36M | -$45M | -$32M | -$16M | -$13M |